Glutathione
54 nonsmoking adults · Oral glutathione · Six-month trial
Glutathione is an endogenous antioxidant tripeptide. This card records oral amounts from a placebo-controlled trial. 54 nonsmoking adults · Oral glutathione · Six-month trial.
Reviewed 2026-10-17. A source reference, not a personal treatment plan. Discuss treatment decisions with a qualified clinician.
Dose reference
| STUDY CONTEXT | Dose | Frequency | Context |
|---|---|---|---|
| Lower oral arm | 250 mg | Daily · 6 months | Source |
| Higher oral arm | 1,000 mg | Daily · 6 months | Source |
Biomarker changes do not establish prevention of disease or justify skin-whitening injections. Oral, liposomal, intravenous and topical preparations have different exposure profiles.
Source context
Richie and colleagues measured glutathione stores and related biomarkers after oral supplementation. The two amounts were parallel trial groups.
Reading the dose correctly
Biomarker changes do not establish prevention of disease or justify skin-whitening injections. Oral, liposomal, intravenous and topical preparations have different exposure profiles.
Download the chart
Further reading
Glutathione monograph on myPeptides
References
Does the reference apply to other formulations?
Only the product, preparation and route named here are covered. A shared substance name does not establish an equivalent amount for another formulation.
Where can I read the wider evidence?
The linked myPeptides Glutathione monograph covers the mechanism, human and preclinical evidence, and important distinctions between related substances.